International Urology and Nephrology

, Volume 45, Issue 6, pp 1539–1544 | Cite as

Prostatic biopsies in selected men aged 75 years and older guide key clinical management decisions

  • A. L. Paterson
  • M. K. Sut
  • A. R. Khan
  • H. K. Sharma
Urology - Original Paper

Abstract

Purpose

Increasing life expectancy and PSA testing has increased the number of men over the age of seventy-five presenting for investigation of potential prostate malignancies. Prostatic biopsies provide diagnostic information; however, they are invasive and may not alter management decisions. Therefore, this study aimed to investigate whether prostate biopsies in this age group were justified.

Materials and methods

All men aged 75 years and older who underwent prostatic biopsies between January 2010 and November 2011 at Bedford Hospital were identified and the indication for the biopsies, histopathological results and subsequent management plan investigated.

Results

One hundred and thirty-eight (138) prostatic biopsies were undertaken and malignancies identified in 60/138 (43 %) cases. Prebiopsy PSA and examination findings had a poor positive predictive value of 54 %. Fifty-five out of sixty (92 %) cancers were classified as high or medium risk disease with 30/60 (50 %) patients commencing radiotherapy treatment with curative intent.

Conclusion

In selected patients aged 75 years or over, prostatic biopsies provide important diagnostic information which directly impacts on clinical decisions, supporting their use in this age group.

Keywords

PSA Prostatic biopsies Ageing male Prostate cancer 

References

  1. 1.
    Cancer research UK statistics (2010) www.info.cancerresearchUK.org/cancerstats/. Accessed 15 Sep 2012
  2. 2.
    Schröder FH, Hugosson J, Roobol MJ et al (2012) ERSPC Investigator. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366(11):981–990PubMedCrossRefGoogle Scholar
  3. 3.
    Draisma G, Etzioni R, Tsodikov A et al (2003) Lead times and over detection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95(12):868–878PubMedCrossRefGoogle Scholar
  4. 4.
    Barry MJ (2008) Screening for prostate cancer among men 75 years of age or older. N Engl J Med 359(24):2515–2516PubMedCrossRefGoogle Scholar
  5. 5.
    Walter LC, Bertenthal D, Lindquist K, Konety BR (2006) PSA screening among elderly men with limited life expectancies. JAMA 296(19):2336–2342PubMedCrossRefGoogle Scholar
  6. 6.
    Lu-Yao G, Stukel TA, Yao SL (2003) Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 95(23):1792–1797PubMedCrossRefGoogle Scholar
  7. 7.
    Scales CD Jr, Curtis LH, Norris RD et al (2006) Prostate specific antigen testing in men older than 75 years in the United States. J Urol 176(2):511–514PubMedCrossRefGoogle Scholar
  8. 8.
    National Institute for Health and Care Excellence guidance (2008) http://guidance.nice.org.uk/CG58/Guidance/pdf/English. Accessed 15 Sep 2012
  9. 9.
    Nomikos M, Mariappan P, Zachou A et al (2010) Could prostate biopsies be avoided in men older than 75 years with raised PSA? Urol Int 85(4):410–414PubMedCrossRefGoogle Scholar
  10. 10.
    Wong YN, Mitra N, Hudes G et al (2006) Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296(22):2683–2693PubMedCrossRefGoogle Scholar
  11. 11.
    Alibhai SM, Naglie G, Nam R et al (2003) Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 21(17):3318–3327PubMedCrossRefGoogle Scholar
  12. 12.
    Harnden P, Shelley MD, Clements H et al (2007) The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer 109(1):13–24PubMedCrossRefGoogle Scholar
  13. 13.
    Hanchanale VS, McCabe JE, Javlé P (2010) Radical prostatectomy practice in England. Urol J 7(4):243–248PubMedGoogle Scholar
  14. 14.
    Stangelberger A, Waldert M, Djavan B (2008) Prostate cancer in elderly men. Rev Urol 10(2):111–119PubMedGoogle Scholar
  15. 15.
    Sommers BD, Beard CJ, D’Amico AV (2008) Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 113(8):2058–2067PubMedCrossRefGoogle Scholar
  16. 16.
    Syringos KN, Karapanagiotou E, Harrington KJ (2005) Prostate cancer in the elderly. Anticancer Res 25:4527–4534Google Scholar
  17. 17.
    Kerr LA, Zincke H (1994) Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis. Eur Urol 25(4):305–311PubMedGoogle Scholar
  18. 18.
    Potosky AL, Davis WW, Hoffman RM (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96(18):1358–1367PubMedCrossRefGoogle Scholar
  19. 19.
    Baxter NN, Trepper JE, Durham SB (2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128(4):819–824PubMedCrossRefGoogle Scholar
  20. 20.
    Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293(17):2095–2101PubMedCrossRefGoogle Scholar
  21. 21.
    Johansson JE, Andrén O, Andersson SO et al (2004) Natural history of early, localized prostate cancer. JAMA 291(22):2713–2719PubMedCrossRefGoogle Scholar
  22. 22.
    Bill-Axelson A, Holmberg L, Ruutu M et al (2005) SPCG-4 investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352(19):1977–1984PubMedCrossRefGoogle Scholar
  23. 23.
    Djavan B, Milani S, Remzi M (2005) Prostate biopsy: who, how and when. An update. Can J Urol 12(suppl 1): 44–48, 99–100Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • A. L. Paterson
    • 1
  • M. K. Sut
    • 1
    • 2
  • A. R. Khan
    • 1
  • H. K. Sharma
    • 1
  1. 1.Department of UrologyBedford HospitalBedfordUK
  2. 2.CambridgeUK

Personalised recommendations